Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter collaborative clinical research for safety and effectiveness evaluation of oral anti-Xa inhibitorin edoxaban by catheter ablation perioperative period for patients with non-valvular atrial fibrillation. -Companies led by clinical research-

Next Previous
Search
Trial Profile

Multicenter collaborative clinical research for safety and effectiveness evaluation of oral anti-Xa inhibitorin edoxaban by catheter ablation perioperative period for patients with non-valvular atrial fibrillation. -Companies led by clinical research-

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jul 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Stroke; Thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms KYU-RABLE
  • Sponsors Daiichi Sankyo Company

    • Most Recent Events

    • 16 Jul 2021 Results of exploratory subanalysis (n=477) assessing the effects of catheter ablation using radiofrequency as energy compared with Cryoballoon ablation on myocardial injury; and plasma concentrations of edoxaban and coagulation biomarkers measured immediately before CA and the day after CA, published in the Circulation Journal.
    • 19 Sep 2019 New trial record
    • 12 Sep 2019 Safety and efficacy results published in the Circulation Journal.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top